Guided Therapeutics Inc
OTC:GTHP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guided Therapeutics Inc
Tax Provision
Guided Therapeutics Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guided Therapeutics Inc
OTC:GTHP
|
Tax Provision
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Tax Provision
-$493m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-201%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Tax Provision
-$216.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-5%
|
|
|
Stryker Corp
NYSE:SYK
|
Tax Provision
-$1.3B
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Tax Provision
-$1.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-17%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Tax Provision
-$434.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-10%
|
|
Guided Therapeutics Inc
Glance View
Guided Therapeutics, Inc. engages in the development of medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.
See Also
What is Guided Therapeutics Inc's Tax Provision?
Tax Provision
0
USD
Based on the financial report for Dec 31, 2025, Guided Therapeutics Inc's Tax Provision amounts to 0 USD.
